IVVD Q4 2021 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$83M

Net Income

-$83M

EPS (Diluted)

$-1.95

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$73M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$620M

Total Liabilities

$62M

Stockholders' Equity

$558M

Cash & Equivalents

$542M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$83M	-$64M	-30.1%
Net Income	-$83M	-$64M	-30.0%